Daily Courier: Single Column

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Scinai Immunotherapeutics Ltd ADR (NQ: SCNI )

3.930 -0.350 (-8.18%)
Streaming Delayed Price Updated: 1:58 PM EDT, Jul 25, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 79,358
Open 4.190
Bid (Size) 3.750 (1)
Ask (Size) 3.900 (4)
Prev. Close 4.280
Today's Range 3.430 - 4.190
52wk Range 2.230 - 13.50
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
BioMedNewsBreaks — Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) Receives PEI Feedback Regarding Development, Preclinical Trial of Anti-IL-17 NanoAb
Via Investor Brand Network
Crude Oil Moves Lower; Goldman Sachs Posts Upbeat Results
Via Benzinga
Exposures Fossil Fuels

Performance

YTD
-35.54%
-35.54%
1 Month
+16.96%
+16.96%
3 Month
-16.81%
-16.81%
6 Month
-27.21%
-27.21%
1 Year
-69.77%
-69.77%

More News

Read More
Why SolarEdge Shares Are Trading Lower By 12%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Via Benzinga
Why ASLAN Pharmaceuticals Shares Are Trading Lower By Over 38%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
PLUG Stock Alert: Plug Power Gets Approval for HyVia Acquisition
Via InvestorPlace
M Stock Plunges 13% as Macy’s Calls Off Take-Private Talks
Via InvestorPlace
Nasdaq Surges Over 1%; Lexeo Therapeutics Shares Plummet
Via Benzinga
Why Is Scinai Immunotherapeutics (SCNI) Stock Up 56% Today?
Via InvestorPlace
BioMedNewsBreaks – Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) Releases Successful Preclinical Results In-Vivo Proof-of-Concept Psoriatic Human Skin Model Study
Via Investor Brand Network
Dow Jumps Over 200 Points; NY Empire State Manufacturing Index Falls In July
Via Benzinga
Topics Stocks
Exposures US Equities
Study Explores Starving Malignant Cells to Boost Immunotherapy, Improve DNA Damage
Via Investor Brand Network
BioMedNewsBreaks — Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) Receives Updated LoI from the European Investment Bank
Via Investor Brand Network
SCNI Stock Earnings: Scinai Immunotherapeutics Reported Results for Q1 2024
Via InvestorPlace
BioMedNewsBreaks – Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) Releases Q1 2024 Financial Reports, Business Update
Via Investor Brand Network
Study Finds Infectious Diseases Have Surged Post COVID-19 Pandemic
Via Investor Brand Network
Exposures COVID-19
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
Via InvestorPlace
Why Quantum Shares Are Trading Lower By 45%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Why Chegg Shares Are Trading Higher By Around 20%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Why Ovid Therapeutics Shares Are Trading Lower By 19%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
US Stocks Mixed; Dow Tumbles Over 100 Points
Via Benzinga
Topics Stocks
Exposures US Equities
Why Nurix Therapeutics Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

© Copyright 2015, Daily Courier, Kelowna, BC. Powered by BLOX Content Management System from TownNews.com.